Cervical necrotizing fasciitis (CNF) is a progressive and destructive bacterial infection of the subcutaneous tissue and fascia in the head and neck. The infection often involves a mixture of Streptococcus species, Staphylococcus species, Fusobacterium species or Actinobacter species.1 Importantly CNF is frequently associated with significant morbidity and mortality, usually due to septic shock, disseminated intravascular coagulation (DIC) or multiple organ failures.2 While the cause of head and neck infections is often odontogenic in origin, the progression to life-threatening necrotizing fasciitis is relatively rare in this region given the robust blood supply. A Danish study reported an incidence of 2 per 1,000,000 of the population per year.3 Owing to the infrequent nature of CNF, it may not be recognized by emergency, medical or surgical clinicians until the disease has progressed significantly. Characteristically, patients may appear acutely ill or have a history of recent dental or maxillofacial trauma or long-standing dental neglect. Patients can also present to the emergency department with symptoms of fever, tachycardia, dehydration and hypotension. Clinical examination may reveal clinical signs of cyanosis of the overlying skin and soft tissue of the neck with mottling, cellulitis, tension and necrosis. Crepitus is often felt due to the presence of gas-producing micro-organisms. Severe forms of CNF can also extend to the thoracic, and even the upper abdominal region, which is often life threatening.4 Patients with underlying immune conditions such as diabetes mellitus (DM), human immunodeficiency virus (HIV) infection, or those on long-term immunosuppressants are predisposed to the condition and may have an increase risk or morbidity or mortality.1 Management of the condition requires prompt diagnosis, urgent airway and haemodynamic support, aggressive surgical and serial debridement, if required, and empirical intravenous antibiotics with further tailored treatment dependent on culture and sensitivity.
Discussion
CNF is a rare, but often fatal infectious disease process with a mortality rate of 9.8%.1 Predisposing factors for this pathology include alcoholism, diabetes, HIV infection, immunocompromised status, chronic renal failure, malignancy, intravenous drug abuse and obesity.5 A systematic review by Gunaratne et al reported that CNF was particularly prevalent in individual with diabetes and alcoholism.2 Random venous blood glucose and HbA1C testing is required to test known or newly diagnosed diabetics since adequate glucose control is needed to ensure that the efficacy of treatment is not compromised. In some resource-poor African countries, poor nutritional status and unmanaged oral cavity infections resulting from dental caries, periodontitis, and untreated mandibular fractures with osteomyelitis led to a higher rate of CNF when compared with the rest of the world.6
The clinical progression of CNF can often confound clinicians because, initially, the overlying skin may have a benign appearance, which progresses to become erythematous and tense, mirroring cellulitis or erysipelas.2 Further disease progression and thrombosis of the underlying nutrient vessels coursing through the affected fascia, results in a skin that becomes dusky, and in later stages, purplish-blue necrotic areas may become more apparent.7 Initial localized pain may be replaced by paraesthesia and anaesthesia as cutaneous nerves are destroyed or compressed by the resulting infection.6 Clinical examination of the neck may reveal crepitus as a result of gas-producing micro-organisms.8
Imaging in CNF plays an important role in diagnosis, planning of surgical debridement, assessing response to treatment and identifying disease progression.2 Due to its speed and availability, CT imaging is often the imaging of choice. CT imaging allows the evaluation of any vascular erosion, mediastinitis, progression of infection and the presence of gas bubbles at the infected area.6 As disease progression is dynamic, serial CT imaging may provide more information in assessing the deteriorating patient.
The aetiology of CNF is often dental in origin, making up 47% of cases studied.2 The second and third mandibular molars are often implicated due to the anatomical position of the root apices below the mylohyoid line. Other rarer sources of CNF include supraglottitis, tonsillar or peritonsillar infection, traumatic/iatrogenic injury, major salivary gland infections, cutaneous infections, otitis media, mastoiditis, malignancy and radiotherapy.2
A range of micro-organisms has been recovered from CNF, including species of Streptococcus, Staphylococcus, Prevotella, Peptostreptococcus and Bacteroides.52 Collagenases and hyaluronidases produced by Group A Streptococci cause necrosis and liquefaction of fascia and fat, which occurs early in the disease process.8 Separation of skin from underlying tissues produces the classical ‘dishwater pus’, which often has an offensive smell due to the presence of strict anaerobes.9
A multidisciplinary approach is required to manage these cases successfully. Effective management includes early diagnosis, airway control, aggressive resuscitation, initial broad spectrum antimicrobial therapy, removal of the source of infection with prompt and radical surgical debridement, repeated evaluation, supportive critical care and reconstructive/rehabilitation.7 Aggressive surgical debridement assists in halting the progression of CNF, and prevents the further release of inflammatory mediators that cause systemic complications.7 Involved skin, subcutaneous fat and fascia is removed until bleeding edges are encountered. If encountered, necrotic muscle should also be debrided. Patients should be closely evaluated as repeated surgical debridement is often required. Although the risk of blowout is rare with CNF, a local muscle flap can be used to cover the carotid artery system if it is exposed.9 Reconstruction of any surgical defect can only be undertaken once there is complete resolution of the disease process.
Empirical antimicrobial therapy may vary between hospitals, but the aim is to cover for Gram-positive, Gram-negative and strictly anaerobic bacteria.2 Once culture and antibacterial susceptibility results are available, a more targeted antimicrobial therapy can be provided. The choice of antibiotic therapy may include nitro-imidazoles, cephalosporins, penicillins and aminoglycosides.
Hyperbaric oxygen therapy (HBO) has been used as form of treatment to reduce mortality, duration of hospitalization and the number of surgical debridements.2 The high concentration of oxygen induces free radical formation, which is believed to assist neutrophil-mediated phagocytosis.10 HBO also improves vascularization to the infected area by promoting angiogenesis, collagen formation and capillary budding into the wound.11 However its use is significantly limited by availability, and the logistics of transferring the unwell patient for treatment.